Methods and Devices for Adapting Charge Initiation for an Implantable Defibrillator

• US 20120316612A1
• Filed: 08/17/2012
• Published: 12/13/2012
• Est. Priority Date: 01/25/2005
• Status: Active Grant

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Warren, Jay A., Bardy, Gust H.
• Granted Patent: US 10,052,487 B2
• Time in Patent Office: Days
• US Class Current: 607/7
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/3943 for threshold determination
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

Adaptive methods for initiating charging of the high power capacitors of an implantable medical device for therapy delivery after the patient experiences a non-sustained arrhythmia, and devices that perform such methods. The adaptive methods and devices adjust persistence criteria used to analyze an arrhythmia prior to initiating a charging sequence to deliver therapy. Some embodiments apply a specific sequence of X-out-of-Y criteria, persistence criteria, and last event criteria before starting charging for therapy delivery.

Claims

1. A method of avoiding inappropriate therapy delivery to a patient in an implantable defibrillator, the implantable defibrillator comprising a number of implantable electrodes and operational circuitry for performing cardiac signal analysis and therapy delivery using the implantable electrodes, the method comprising, at a first time:

detecting cardiac events in a patient using the implantable electrodes;

filling an X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, using a predetermined persistence threshold, N, and applying a persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events;

when the persistence rule is met, initiating a charging sequence to charge a capacitor for therapy delivery;

after initiating the charging sequence but before therapy delivery, determining that the cardiac signal data of the patient no longer indicates a need for therapy; and

upon determining, after initiating the charging sequence but before therapy delivery, that the cardiac signal data of the patient no longer indicates a need for therapy, modifying N to increase the quantity of consecutive cardiac events required to meet the persistence threshold and storing N for use in the future;

and the method further comprising, at a second time;

detecting cardiac events in the patient using the implantable electrodes;

filling the X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, applying the persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events, wherein N, when applied at the second time, is modified in view of the occurrence of the first time; and

finding that the persistence rule is not met due to the increase in N at least once.

2. The method of claim 1 wherein the X-out-of-Y filter is filled by increasing X when a detected cardiac event, when analyzed by the operational circuitry, is found to exceed a rate threshold.

3. The method of claim 1 wherein the X-out-of-Y filter is filled by increasing X when a detected event, when analyzed by the operational circuitry, meets one of the two following criteria:

the detected event indicates a rate that exceeds a fast rate threshold;

or

the detected event indicates a rate below the fast rate threshold but above a low rate threshold and meets detection enhancement criteria that indicate a malignant arrhythmia.

4. The method of claim 1 wherein at least one of the electrodes is disposed on a lead that is emplaced transvenously in the patient.

5. The method of claim 1 wherein all of the electrodes are disposed subcutaneously in the patient without entering the heart or contacting cardiac tissue.

6. The method of claim 1 wherein the X-out-of-Y filter is applied by using an 18-out-of-24 rule as the predetermined treatment threshold.

7. An implantable defibrillator comprising a number of implantable electrodes and operational circuitry for performing cardiac signal analysis and therapy delivery using the implantable electrodes, the operational circuitry being configured to perform the following:

at a first time;

detecting cardiac events in a patient using the implantable electrodes;

filling an X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, using a predetermined persistence threshold, N, and applying a persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events;

when the persistence rule is met, initiating a charging sequence to charge a capacitor for therapy delivery;

after initiating the charging sequence but before therapy delivery, determining that the cardiac signal data of the patient no longer indicates a need for therapy; and

upon determining, after initiating the charging sequence but before therapy delivery, that the cardiac signal data of the patient no longer indicates a need for therapy, modifying N to increase the quantity of consecutive cardiac events required to meet the persistence threshold and storing N for use in the future;

and at a second time;

detecting cardiac events in the patient using the implantable electrodes;

filling the X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, applying the persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events, wherein N, when applied at the second time, is modified in view of the occurrence of the first time; and

finding that the persistence rule is not met due to the increase in N at least once.

8. The implantable defibrillator of claim 7 wherein the operational circuitry is further configured such that the X-out-of-Y filter is filled by increasing X when a detected cardiac event, when analyzed by the operational circuitry, is found to exceed a rate threshold.

9. The implantable defibrillator of claim 7 wherein the operational circuitry is further configured such that the X-out-of-Y filter is filled by increasing X when a detected event, when analyzed by the operational circuitry, meets one of the two following criteria:

the detected event indicates a rate that exceeds a fast rate threshold;

or

the detected event indicates a rate below the fast rate threshold but above a low rate threshold and meets detection enhancement criteria that indicate a malignant arrhythmia.

10. The implantable defibrillator of claim 7 wherein the operational circuitry is configured to apply the X-out-of-Y filter by using an 18-out-of-24 rule as the predetermined treatment threshold.

11. A method of identifying an arrhythmia in an implantable defibrillator, the implantable defibrillator including a plurality of implantable electrodes coupled to operational circuitry for analyzing cardiac signals and generating therapy outputs, the method comprising:

detecting events using signals captured by the electrodes;

determining whether individual detected events indicate a likely arrhythmia by the use of an X-out-of-Y filter;

applying therapy criteria to the X-out-of-Y filter and determining the therapy criteria are met;

when the therapy criteria are met, applying persistence criteria to determine whether the therapy criteria are met for a quantity of consecutive detected events;

determining the persistence criteria are met;

when the persistence criteria are met, applying last event criteria to determine whether at least one most recent detected events meets treatment criteria;

if the last event criteria are met, then initiating a charging sequence to prepare for therapy delivery to the patient;

or

if the last event criteria are not met, waiting for another detected event and re-applying the therapy criteria, persistence criteria, and last event criteria until either;

the persistence criteria or therapy criteria are no longer met;

or

all of the last event criteria, persistence criteria, and therapy criteria are met simultaneously.